European Archives - Page 501 of 1136 - European Medical Journal

EMJ Microbiology 3.1 2022 Feature Image

Past, Present, and Future of Pandemics: Preparedness and First Defences

As expected, debate and expert discussion at the 32nd European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in April …

EMJ Microbiology 3.1 2022 Feature Image

Acute Bacterial Skin and Skin Structure Infections: Advantages and Disadvantages of Early Discharge and Outpatient Parenteral Antibiotic Therapy

Acute bacterial skin and skin structure infections (ABSSSI) can require long periods of antibiotic therapy. If an ABSSSI…

EMJ Microbiology 3.1 2022 Feature Image

Factors Associated with Rehospitalisation for Cellulitis and How to Mitigate Against Them

Gavin Barlow, Hull York Medical School, UK, spoke with the EMJ about risk factors for the bacterial infection cellulitis…

Reassessing Paediatric Allergen-Specific Immunotherapy Studies

Allergen-specific immunotherapy (AIT) works well both in children and adults. An often-alleged gap between the level of evidence of AIT efficacy…

Getting to grips with customer experience

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with an interview with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD.

A Self-Resolving Flare of Psoriasis after COVID-19 Vaccination

A 63-year-old female with history of psoriasis, degenerative disc disease, and osteoarthritis of the hands and knees presented with…

A Study in Urology

Leslie Moffat discusses how males with family members who have had breast cancer could be at a higher risk of getting prostate cancer.

Access to medicine in Latin America

Track the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.

Novel targets for therapy in TD β-Thalassaemia

The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…

Pharma in South Africa, access, pricing and reimbursement

In this episode, GOLD is joined by two international experts in market access, talking about pricing, reimbursement and more in South Africa and Europe.